Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy

PURPOSE: Abnormal fatty acid (FA) synthesis is one of the common features of cancer. Fatty acid synthase (FASN), a multifunctional enzyme playing a key role in biosynthesis of FA, is up-regulated in prostate, breast, and lung carcinomas. Orlistat is a FDA-approved anti-obesity drug that inhibits the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankaranarayanapillai, Madhuri, Zhang, Nianxiang, Baggerly, Keith A., Gelovani, Juri G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591534/
https://www.ncbi.nlm.nih.gov/pubmed/22886728
http://dx.doi.org/10.1007/s11307-012-0587-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591534/
https://www.ncbi.nlm.nih.gov/pubmed/22886728
http://dx.doi.org/10.1007/s11307-012-0587-6

Ejemplares similares